APONVIE
NDC 47426-401, APREPITANT, emulsion, from Heron Therapeutics, Inc..
- Product NDC
- 47426-401
- Status
- Listed
- Labeler
- Heron Therapeutics, Inc.
- Dosage form
- EMULSION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA216457
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/47426-401 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- APREPITANT32 mg/4.4mL
Pharmacologic classes
Cytochrome P450 2C9 Inducers [MoA]; Cytochrome P450 3A4 Inducers [MoA]; Cytochrome P450 3A4 Inhibitors [MoA]; Neurokinin 1 Antagonists [MoA]; Substance P/Neurokinin-1 Receptor Antagonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 47426-401-10 | 47426040110 | 10 VIAL, GLASS in 1 CARTON (47426-401-10) / 4.4 mL in 1 VIAL, GLASS (47426-401-01) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/d1b111eb-659a-496b-a86a-8f0fa370f147Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=47426-401
Use it
Look up 47426-401 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/47426-401 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 47426-401. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.